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Abstract Wild-type and palmitoylation defective mutants of the 
murine G protein G n a were transfected into HEK293 cells. 
Wild-type G n a was membrane associated, Cys9Ser CyslOSer 
G n a was present in the soluble fraction whilst both Cys9Ser 
G n a and CyslOSer G n a were distributed between the fractions. 
Expression of the rat TRH receptor resulted in agonist 
stimulation of inositol phosphate accumulation. The degree of 
stimulation produced by TRH following co-transfection of the 
palmitoylation-resistant forms of G n a compared to the wild-
type protein correlated with the amount of membrane-associated 
G protein. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The phosphoinositidase C-linked G proteins, G q a and G n a 
can be post-translationally acylated on adjacent cysteine res-
idues at position 9 and 10 [1-3]. Previous studies on acylation-
resistant mutants of G q a have indicated both that they are 
either entirely or partially cytosolic [1] or that the mutat ions 
did not have a significant effect on particulate versus cytosolic 
partitioning [3,4]. However, particulate Cys9Ala CyslOAla 
G q a has been reported to be resistant to solubilisation by 
sodium cholate, the detergent routinely used in the early 
stages of G-protein purification [4], which may indicate it to 
represent an incorrectly folded or denatured protein. 
We have recently noted that a rodent version of G n a can 
be effectively resolved from primate versions of the same G 
protein in urea-containing SDS-PAGE systems [5,6] and have 
taken advantage of this fact to generate a stable cell line 
derived from (human) HEK293 cells which expresses both 
human and murine versions of this G protein. Concomitant 
activation of both the human and murine versions of this G 
protein could then be shown to be produced by expression of 
the long isoform of the rat thyrotropin-releasing hormone 
(TRH) receptor [6]. 
In the current study we utilise the capacity to unambigu-
ously discriminate human and murine forms of G n a to ex-
amine the role of potential post-translational acylation and 
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cellular location on interactions of the G protein with both 
the rat T R H receptor and phosphoinositidase C. 
2. Materials and methods 
2.1. Materials 
[3H]Inositol was from Amersham International. Lipofectamine and 
all cell culture reagents were from Life Technologies (Paisley, UK). 
Nitrocellulose was from Costar (Cambridge, MA). All other reagents 
were from Fisons and were of the highest grade commercially avail-
able. 
2.2. Generation of CysÇSer, CyslOSer and Cys9Ser CyslOSer mutants 
of murine Gna 
Murine G n a in the mammalian expression vector pCMV was a 
kind gift from Dr. M.I. Simon, California Institute of Technology, 
California, USA. The Cys9Ser, CyslOSer and Cys9Ser CyslOSer mu-
tations were generated as in [3] except that they were subcloned into 
pcDNA3 (Invitrogen) for transfection. 
2.3. Maintenance and transfection of HEK293 cells 
HEK293 cells were maintained in DMEM supplemented with 10% 
(v/v) newborn calf serum, 2 mM L-glutamine, 100 U/ml penicillin and 
100 ug/ml streptomycin in an atmosphere of 5% CO2 at 37°C. Cells 
were transfected at approximately 40% confluency with pcDNA3 con-
taining either the long isoform of the rat TRH receptor [6,7] in iso-
lation or in combination with wild-type, Cys9Ser, CyslOSer or Cys-
9Ser CyslOSer murine G n a using Lipofectamine reagent (Life 
Technologies, Paisley, UK) according to the manufacturers' instruc-
tions. 
2.4. Inositol phosphate measurements 
Twenty-four hours after transfection the cells were reseeded into 12-
well plates and allowed to grow for a further 24 h. Cells were then 
labelled with [3H]inositol (1 uCi/ml) and 24 h later total [3H]inositol 
phosphate production was measured either basally or upon addition 
of TRH (10 uM) as in [6]. 
2.5. Sodium cholate extractions 
Cells were harvested, freeze/thawed, resuspended in 400 ul of Tris/ 
EDTA and homogenised with a Teflon/glass homogenizer. Following 
a low-speed centrifugation, to remove unbroken cells and the nuclear 
pellet (PI), the samples were centrifuged at 200000Xg for 30 min at 
4°C and the soluble cytoplasmic fraction (C) retained. The particulate 
fraction (P2) was resuspended in a final volume of 500 ul of extraction 
buffer (10 mM Tris-HCl, pH 7.4, 0.1 mM EDTA, 150 mM NaCl 
containing 1% (w/v) sodium cholate). The samples were incubated 
at 4°C with stirring for 1 h then centrifuged at 200 000 X g for 30 
min at 4°C generating a soluble supernatant (S) and insoluble pellet 
(P)-
2.6. Electrophoretic separation of species variants of Gna 
Particulate, sodium cholate solubilised and cytosolic fractions were 
electrophoresed by SDS-PAGE in 10% (w/v) acrylamide gels contain-
ing 6 M urea. These conditions separate murine G n a from simian 
and human G n a and G q a [5,6]. Proteins were transferred to nitro-
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cellulose and probed with antiserum CQ which recognises the C-ter-
minal decapeptide of Gna and Gqa which is entirely conserved in all 
of these species and visualised as described [8]. Following develop-
ment, blots were scanned and quantitated on a Bio-Rad GS670 imag-
ing densitometer (Bio-Rad, Hemel Hempstead, UK) linked to an Ap-
ple Macintosh Quadra 800 computer. 
3. Results 
The endogenously expressed forms of the human phospho-
inositidase C-linked G-proteins G q a and G n a in HEK293 
cells co-migrated in 6 M urea-containing SDS-PAGE and 
could be detected using an antiserum [8] directed against the 
C-terminal decapeptide which is entirely conserved in these 
two G proteins [9]. These proteins were present exclusively 
in the P2 particulate fraction and were completely solubilised 
(S) from this membrane fraction by treatment with sodium 
cholate (1%, 1 h, 4°C) (Fig. 1, lanes 1^1). Following transient 
expression of wild-type murine G n a in HEK293 cells, this 
polypeptide could be detected following urea-containing 
SDS-PAGE as a more rapidly migrating polypeptide than 
the human form. Fractions of this polypeptide could be de-
tected in both the cytosolic as well as the P2 particulate frac-
tion but as with the endogenous human GnOc/Gqa essentially 
all of the P2 particulate murine G n a was solubilised from this 
fraction by treatment with sodium cholate (Fig. 1, lanes 5-8). 
Expression of either Cys9Ser or CyslOSer mutations of mur-
ine G n a altered the cellular distribution profile of the G 
protein with greater fractions of the expressed polypeptides 
now being located in the cytosolic fractions. However, the 
majority of the P2 particulate Cys9Ser and CyslOSer murine 
G n a was still solubilised by sodium cholate treatment (Fig. 1, 
lanes 9-16). Expression of a Cys9Ser CyslOSer double muta-
tion of murine G n a resulted in the vast majority of the im-
munodetected protein being cytosolic and poor sodium chol-
ate solubilisation of the small amount of P2 particulate 
located G protein (Fig. 1, lanes 17-20). However, as antici-
pated, all of the endogenous human G n a / G q a was both 
present in the P2 particulate fractions of cells transfected to 
express the various murine G n a mutations and was solubi-
lised by sodium cholate (Fig. 1). 
We have previously shown that Cys9 and Cys10 are the sites 
for post-translational palmitoylation of murine Gnoc and that 
mutation of both Cys residues to Ser entirely prevents palmi-
toylation of the expressed protein whilst mutation of either 
Cys9 or Cys10 results in a decline in the palmitoylation ca-
pacity of the expressed proteins to below 20% of the wild-type 
protein [2]. We thus assessed the capacity of the expressed 
wild-type and palmitoylation-resistant forms of G n a to me-
diate activation of a phosphoinositidase C. A mixture of alu-
minum chloride (30 |oM) and sodium fluoride (10 mM) (to 
generate fluoroaluminate ions) was added to either mock 
transfected HEK293 cells or those transfected with wild-type 
murine G n a or the Cys9Ser, CyslOSer or Cys9Ser CyslOSer 
forms of this G protein and which had subsequently been 
prelabelled with [3H]inositol for 24 h. A small stimulation of 
[3H]inositol phosphate generation was observed in the mock 
transfected cells (Fig. 2) presumably due to activation of the 
endogenous human Gna/G q a . A much more robust stimula-
tion in response to fluoroaluminate was observed following 
expression of wild-type murine G n a (Fig. 2) whereas expres-
sion of each of the palmitoylation defective mutants resulted 
in a considerably more limited stimulation of [3H]inositol 
Fig. 1. Subcellular localisation and sodium cholate solubilisation of particulate wild-type and palmitoylation negative mutant forms of murine 
GnOt after transient expression in HEK293 cells. HEK293 cells were either mock transfected (1^1) or transfected with cDNAs encoding wild-
type (5-8), CyslOSer (9-12) Cys9Ser (13-16) or Cys9Ser CyslOSer murine Gna (17-20). Cells were then homogenised and separated into PI 
particulate (PI) (1,5,9,13,17), cytosolic (C) (2,6,10,14,18) or P2 particulate fractions. The P2 particulate fractions were extracted with sodium 
cholate and separated into solubilised (S) (3,7,11,15,19) or insoluble particulate (P) (4,8,12,16,20) fractions. All samples were resolved by SDS-
PAGE containing 6 M urea, transferred to nitrocellulose and immunoblotted using antiserum CQ [8]. 






Fig. 2. The effect of fluoroaluminate and Gna palmitoylation po-
tential on phosphoinositidase C activity. HEK293 cells were either 
mock transfected (1) or transfected with cDNAs (1 |xg) encoding 
wild-type Gna (2), Cys9Ser Gna (3), CyslOSer Gna (4) or Cys-
9Ser, CyslOSer Gna (5) in pcDNA3 as described in Section 2. 
Twenty-four hours after transfection the cells were reseeded into 12-
well plates and allowed to grow for a further 24 h. Cells were then 
labelled with [3H]inositol (1 uCi/ml) and 24 h later total [3H]inositol 
phosphate production was measured either basally (open bars) or 
upon addition of fluoroaluminate (10 mM NaF+30 uM AICI3) 
(filled bars). Data are presented as total [3H]inositol phosphates 
genera ted/10 000 dpm in [3H]inositol containing lipids and represent 
means ± SEM from triplicate assays derived from one of three simi-
lar experiments performed. 
phosphate production compared to that achieved with the 
wild-type G protein (Fig. 2). 
We have previously demonstrated that stable expression of 
the long isoform of the rat TRH receptor in HEK293 cells 
allows substantial stimulation of inositol phosphate produc-
tion in response to addition of TRH [10]. Transient transfec-
tion of HEK293 cells with 0.2 ug of this TRH receptor cDNA 
resulted in a very modest stimulation of [3H]inositol phos-
phate production from [3H]inositol prelabelled cells (Fig. 3). 
This could be increased by transfection of a higher level of 
TRH receptor cDNA (Fig. 3). At both levels of TRH receptor 
cDNA greater [3H]inositol phosphate production was 
achieved by co-expression of wild-type murine G n a (Fig. 3). 
In contrast to the capacity of wild-type murine G n a to 
promote TRH-induced [3H]inositol phosphate production 
upon co-expression with the TRH receptor the capacity of 
the Cys9Ser and CyslOSer mutations of G n a was very limited 
(Fig. 4) and no stimulation above that observed in TRH re-
ceptor only transfected HEK293 cells was observed following 
co-expression of the TRH receptor and Cys9Ser CyslOSer 
G n a (Fig. 4). 
4. Discussion 
Post-translational acylation of cysteine residues close to the 
N-terminus occurs in all G-protein a-subunits with the excep-
tion of the transducins of the visual system [11-13]. In the 
cases of the pertussis toxin-insensitive, phosphoinositidase 
C-linked G proteins G q a and G n a attachment of palmitate 
(and potentially other acyl groups) can occur on adjacent 
cysteines at positions 9 and 10 [1-3]. All previous studies on 
the potential role of post-translational acylation have utilised 
Gqa. Although it is generally assumed that Gqa and G n a can 
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function interchangeably there is no evidence that this is so in 
respect of their acylation properties. 
Both Gqa and G n a are very widely expressed [9] and this 
raises difficulties in examining the cellular distribution and 
function of mutant forms of these proteins without substantial 
overexpression beyond normal levels. We have recently found 
an alternative to this accompanying our observations that 
primate and rodent forms of G n a migrate differently in 
urea-containing SDS-PAGE even though they are highly sim-
ilar in primary amino acid sequence [5,6]. In the current ex-
periments we have taken advantage of the endogenous expres-
sion of human G n a in HEK293 cells by examining the 
cellular distribution and detergent solubility of this protein 
when compared to transiently introduced wild-type and acyl-
ation-resistant mutants of murine G n a . 
Because of our previous observations that immunoreactive 
transiently expressed G protein present in the particulate pel-
let following low-speed centrifugation of hypotonically lysed 
cells largely represents improperly folded or denatured protein 
[2] we did not use these fractions for further analysis. All of 
the endogenous human G n a / G q a was present in all experi-
ments in the high-speed particulate fraction (P2) and could be 
solubilised from this by treatment with sodium cholate (Fig. 
1). These observations provided a reference point for all stud-
ies on both wild-type and mutated forms of murine G n a . 
Essentially all of the particulate wild-type murine G n a could 
be extracted with sodium cholate (Fig. 1). The percentage of 
P2 particulate associated forms of murine G n a varied with 
the mutation introduced, with replacement of both Cys9 and 
Cys10 by Ser resulting in only a fraction of the protein being 
membrane associated although the bulk of this material could 
be extracted with sodium cholate. By contrast, the expressed 







Fig. 3. Expression of the TRH receptor results in activation of 
phosphoinositidase C by co-expressed murine Gna. HEK293 cells 
were transfected with cDNAs encoding the long isoform of the rat 
TRH receptor (0.2 ug (1-3) or 1.0 ug (4-5)) without (1,4) or with 
wild-type murine Gna (0.8 ug (2), 1.0 ug (5) or 1.8 ug (3)) in 
pcDNA3 (to maintain the total cDNA added per transfection at 2.0 
Ug) as described in Section 2. Twenty-four hours after transfection 
the cells were reseeded into 12-well plates and allowed to grow for 
a further 24 h. Cells were then labelled with [3H]inositol (1 uCi/ml) 
and 24 h later total [3H]inositol phosphate production was meas-
ured either basally (open bars) or upon addition of TRH (10 uM) 
(filled bars). Data are presented as total [3H]inositol phosphates 
generated/10000 dpm in [3H]inositol containing lipids and represent 
means ± SEM from triplicate assays derived from one of three simi-
lar experiments performed. 
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Fig. 4. Activation of phosphoinositidase C by the TRH receptor: ef-
fects of the palmitoylation potential of murine Gua. HEK293 cells 
were transfected with cDNAs encoding the long isoform of the rat 
TRH receptor (1 |ig) without (1) or in combination with wild-type 
Gua (2), Cys9Ser Gua (3), CyslOSer G u a (4) or Cys9Ser Cys-
lOSer Gncc (5) (all at 1 ug) in pcDNA3 as described in Section 2. 
Twenty-four hours after transfection the cells were reseeded into 12-
well plates and allowed to grow for a further 24 h. Cells were then 
labelled with [3H]inositol (1 uCi/ml) and 24 h later total [3H]inositol 
phosphate production was measured either basally (open bars) or 
upon addition of TRH (10 uM) (filled bars). Data are presented as 
total [3H]inositol phosphates generated/10 000 dpm in [3H]inositol 
containing lipids and represent means ± SEM from triplicate assays 
derived from one of three similar experiments performed. 
although wild-type murine G u a was strongly activated by 
fluoroaluminate (which mimics the terminal (y) phosphate of 
GTP and thus activates the G protein) to stimulate phospho-
inositidase C each of the three Cys to Ser mutants also al-
lowed a significant, if limited, degree of stimulation of phos-
phoinositidase C, which was not different between the two 
single mutations and the double mutation. Although Edger-
ton et al. [4] reported weak stimulation of a phospholipase C 
by Cys9Ala Cys 10Ala G qa they did not test the two equiv-
alent single mutants and Hepler et al. [3] have noted poor 
stimulation of phospholipase Cßl by a Cys9Ser CyslOSer 
double mutant of G q a whereas the two single mutants acti-
vated normally. Our results thus vary from both of these 
reports. 
The rat TRH receptor in HEK293 cells can interact with 
stably co-expressed human and murine G u a [6]. Transient 
transfection of this receptor into HEK293 cells allowed ago-
nist stimulation of phosphoinositidase C activity and co-ex-
pression of the receptor along with wild-type murine G u a 
resulted in substantially greater activity (Fig. 3). TRH stim-
ulation of phosphoinositidase C beyond that due to endoge-
nous GiiOe/Gqa was also observed following co-transfection 
with both murine Cys9Ser G u a and CyslOSer G u a but not 
with the double mutant (Fig. 4). The degree of stimulation by 
TRH was correlated with the level of the P2 particulate mur-
ine G u a forms and with their extraction by sodium cholate. 
As noted above, both Cys9Ser and CyslOSer G q a have been 
reported to be activated by receptor agonist (although to a 
lower level than the wild-type protein) with the double mutant 
showing little agonist dependent function [1]. As interaction 
with a receptor must be dependent upon physical location at 
or close to the plasma membrane the lack of ability of the 
cytosolic double Cys-Ser mutant G u a to be stimulated by the 
TRH receptor was anticipated. The capacity of acylation re-
sistant forms of phosphoinositidase C-linked G proteins to 
produce a small degree of stimulation of the effector enzyme 
following addition of fluoroaluminate (Fig. 2) may reflect 
both the cellular location of the effector and the suggestion 
that agonist-induced deacylation and cellular translocation of 
G-protein a-subunits from the membrane may occur upon 
activation [14,15]. However the weak stimulation compared 
to that produced by wild-type G u a demonstrates that the 
acylation deficient mutants are functionally severely compro-
mised. As such, membrane attachment and the potential for 
acylation contributes to, but may not be an absolute require-
ment, for direct G-protein regulation of phosphoinositidase C 
but is required to allow regulation by receptor agonists. 
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